Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 133, Issue 5, Pages 1137-1139Publisher
ELSEVIER SCIENCE INC
DOI: 10.1038/jid.2012.505
Keywords
-
Categories
Ask authors/readers for more resources
Despite the growing focus on microRNAs (miRNAs) as novel diagnostic tools and therapeutic targets in cancer, global characterization of miRNA expression patterns and their specific targets in melanoma has lagged. In this issue, Reuland et al. (2013) identify miR-26a as being specifically downregulated in human melanoma cells. They further establish Silencer of Death Domains as a novel target for miR-26a, which functionally mediates melanoma cell death. These findings suggest that miR-26a may serve as a promising novel therapy for subsets of melanoma. Journal of Investigative Dermatology (2013) 133, 1137-1139. doi:10.1038/jid.2012.505
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available